Citi

One of Asia’s most consistent sovereign issuers, the Republic of Indonesia, is set to tap the market four times in three different currencies next year, according to a spokesperson for the country’s Directorate General of Debt Management.

Mobile game developer Feiyu Technology International Co priced its IPO in the middle at HK$2.20 ($0.28) a share to raise HK$659.21m, even as books were covered across the price range.

Export Development Canada left US dollar investors with a sweet taste when it issued the last expected dollar benchmark of 2014. It printed a deal in line with — or slightly through — its curve that was still well oversubscribed and traded tighter versus Treasuries in secondary.

Alibaba’s landmark $8bn bond has had an unpredictable time in secondary markets in the week since it was completed, as US and Asian investors reflected different views on pricing. But this does not take away from the deal’s achievements.

The Republic of Indonesia has picked the banks that will sit on its bond panel next year, dropping one bank and appointing two new members.

Repsol, the Spanish oil and gas company, has issued a €500m 12 year bond, extending its maturity profile by five years and only had to pay a small new issue premium, according to a banker.

Pakistan has set the final terms for its five year dollar benchmark sukuk. The deal will be between $750m and $1bn. Pricing is expected to follow on Wednesday in the early afternoon, London time.

China Development Bank’s financial arm of CDB Leasing failed to outshine on its comeback through a five year and ten year dual tranche offering on November 25 despite the status of the ultimate parent as the country’s biggest policy bank.

Telekom Austria, the telephone and internet services provider, has raised over €1bn in its first capital increase since Carlos Slim’s América Móvil (AMX) acquired a majority stake in the company earlier this year.

Guarantor: Canada

Export Development Canada built an oversubscribed book for a new dollar benchmark on Tuesday, despite pricing flat to its curve. The issuer’s rarity and the deal’s proximity to the Thanksgiving holiday in the US on Thursday may have helped boost demand for the paper.

GlaxoSmithKline has returned to the euro bond market after a five year absence with a big double tranche transaction. The UK pharmaceuticals company priced €1.5bn of five year and €1bn of 10 year bonds on Tuesday.